Skip to main content

Table 2 Comparison of sensitiser enhancement ratios (SER) obtained using 160 kV and 6 MV X-ray sources

From: Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment

 

160 kVp

6 MV

DU145

+ 1 µg Citrate-AuNP

0.9

1

+ RALA-AuNP

1.23

1.21

PC-3

+ 1 µg Citrate-AuNP

1.15

1.04

+ RALA-AuNP

1.54

1.31

PNT2-C2

+ 1 µg Citrate-AuNP

1.1

1

+ RALA-AuNP

0.96

1.014